1 Min Read
May 17 (Reuters) - Jubilant Life Sciences Ltd
* Says Jubilant receives ANDA approval for Amlodipine and Olmesartan Medoxomil tablets
* Says drugs used for the treatment of hypertension Source text - (bit.ly/2qPSiOO) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.